Nonsense mutations in the PAX3 gene cause Waardenburg syndrome type Ⅰ in two Chinese patients
- Author:
- No author available
- Journal Title:
- CHINESE MEDICAL JOURNAL
- Issue:
- 1
- DOI:
- No doi available
- Key Word:
- Waardenburg syndrome type 1;PAX3 gene;mutation
Abstract： Background Waardenburg syndrome type Ⅰ (WS1) is an autosomal dominant disorder characterized by sensorineural hearing loss, pigmental abnormalities of the eye, hair and skin, and dystopia canthorum. The gene mainly responsible for WS1 is PAX3 which is involved in melanocytic development and survival. Mutations of PAX3 have been reported in familiar or sporadic patients with WS1 in several populations of the world except Chinese. In order to explore the genetic background of Chinese WS1 patients, a mutation screening of PAX3 gene was carried out in four WS1 pedigrees. Methods A questionnaire survey and comprehensive clinical examination were conducted in four Chinese pedigrees of WS1. Genomic DNA from each patient and their family members was extracted and exons of PAX3 were amplified by PCR. PCR fragments were ethanol-purified and sequenced in both directions on an Abl_Prism 3100 DNA sequencer with the BigDye Terminator Cycle Sequencing Ready Reaction Kit. The sequences were obtained and aligned to the wild type sequence of PAX3 with the GeneTool program. Results Two nonsense PAX3 mutations have been found in the study population. One is heterozygous for a novel nonsense mutation S209X. The other is heterozygous for a previously reported mutation in European population R223X. Both mutations create stop codons leading to truncation of the PAX3 protein. Conclusions This is the first demonstration of PAX3 mutations in Chinese WS1 patients and one of the few examples of an identical mutation of PAX3 occurred in different populations.
- [1]Cupples LA,Read AP,Asher JH Jr,etc.Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations.[J].1998,102(5).
- [2]Valerie E, Newton.Clinical features of the Waardenburg syndromes.[J].2002,61.
- [3]E G, Puffenberger,E R, Kauffman,S, Bolk,etc.Identity-by-descent and association mapping of a recessive gene for Hirschsprung disease on human chromosome 13q22.[J].1994,3.
- [4]Erik G. Puffenberger,Kiminori Hosoda,Sarah S. Washington,etc.A missense mutation of the endothelin-B receptor gene in multigenic hirschsprung's disease[J].1994,79(7).
- [5]C T, Baldwin,C F, Hoth,R A, Macina,etc.Mutations in PAX3 that cause Waardenburg syndrome type I: ten new mutations and review of the literature.[J].1995,58(2).
- [6]L A, Farrer,K S, Arnos,J H, Asher,etc.Locus heterogeneity for Waardenburg syndrome is predictive of clinical subtypes.[J].1994,55.
- [7]M.Tassabehjl,V. E.Newton,K.Leverton,etc.PAX3 gene structure and mutations: close analogies between Waardenburg syndrome and theSplotchmouse[J].1994,3(7).
- [8]Tassabehji, M.,Read, A.P..Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene.[J].1992,355(6361).
- [9]C T, Baldwin,N R, Lipsky,C F, Hoth,etc.Mutations in PAX3 associated with Waardenburg syndrome type I.[J].1994,3(3).
- [10]M, Tassabehji,V E, Newton,X Z, Liu,etc.The mutational spectrum in Waardenburg syndrome.[J].1995,4.
- [11]A P Read,V E Newton.Waardenburg syndrome.[J].1997,34(8).
- [12]C R, Kissinger,B S, Liu,E, Martin-Blanco,etc.Crystal structure of an engrailed homeodomain-DNA complex at 2.8 A resolution: a framework for understanding homeodomain-DNA interactions.[J].1990,63.
- [13]W J, Pavan,S, Mac,M, Cheng,etc.Quantitative trait loci that modify the severity of spotting in piebald mice.[J].1995,5.
- [14]E, Dahl,H, Koseki,R, Balling.Pax genes and organogenesis.[J].1997,19(9).